54092-063 : Agrylin 0.5 mg Oral Capsule
| NDC: | 54092-063 |
| Labeler: | Shire Us Manufacturing Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Agrylin |
| Dosage Form: | Oral Capsule |
| Application #: | NDA020333 |
| Rev. Date: |
Appearance:
| Markings: | S063 |
| Shapes: |
Capsule |
| Colors: |
 White |
| Size (mm): | 14 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 54092-063-01: 100 CAPSULE IN 1 BOTTLE (54092‑063‑01)
Active Ingredients:
- Anagrelide Hydrochloride Anhydrous
Dosage Strength:
- .5 mg
Inactive Ingredients:
- Anhydrous Lactose
- Crospovidone
- Lactose Monohydrate
- Magnesium Stearate
- Cellulose, Microcrystalline
- Povidones
Pharmaceutical Classes:
- Decreased Platelet Production [PE]
- Phosphodiesterase 3 Inhibitors [MoA]
- Platelet-reducing Agent [EPC]
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 54092-055Next: 54092-073 >
Related Discussions:
side effects of agrylin
I have been using agrylin for 4 months and suffering from excessive hair lose ## Common side effects of Agrylin are head... 1 reply
I have been using agrylin for 4 months and suffering from excessive hair lose ## Common side effects of Agrylin are head... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.